Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
58.6M
-
Number of holders
-
148
-
Total 13F shares, excl. options
-
31.4M
-
Shares change
-
+1.36M
-
Total reported value, excl. options
-
$2.22B
-
Value change
-
+$86.5M
-
Put/Call ratio
-
0.86
-
Number of buys
-
81
-
Number of sells
-
-77
-
Price
-
$70.59
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) as of Q3 2015
190 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q3 2015.
AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) has 148 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.4M shares
of 58.6M outstanding shares and own 53.52% of the company stock.
Largest 10 shareholders include FMR LLC (5.62M shares), WELLINGTON MANAGEMENT GROUP LLP (4.98M shares), Capital World Investors (3.03M shares), BB BIOTECH AG (2.11M shares), Flagship Ventures 2007 General Partner LLC (1.93M shares), VANGUARD GROUP INC (1.81M shares), FIRST TRUST ADVISORS LP (1.62M shares), Capital International Investors (1.35M shares), BlackRock Fund Advisors (767K shares), and BlackRock Institutional Trust Company, N.A. (612K shares).
This table shows the top 148 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.